Use of recombinant activated factor VII for bleeding following resection of mediastinal angiosarcoma

被引:0
|
作者
Arora, D. [1 ]
Mehta, Y. [1 ]
Trehan, N. [1 ]
机构
[1] Medanta Medicity, Medanta Inst Crit Care & Anaesthesiol, Sector 38, Gurgaon, Haryana, India
关键词
recombinant factor VII; mediastinal tumor; angiosarcoma;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sarcomatous lesions of the mediastinum usually present as aggressive and multicentre masses often attached to adjoining structures including heart and lungs. A forty one year male diagnosed with sarcomatous lesion in mediastinum presented for biopsy through mid-sternotomy later confirmed as angiosarcoma on histopathology. Patient bled excessively after surgery and required reopening of the chest. However, bleeding could not be controlled with reopening, blood products and packing of the mediastinal cavity. Bleeding could only be controlled by using recombinant activated factor VII as rescue therapy without any adverse effects.
引用
收藏
页码:197 / 201
页数:5
相关论文
共 50 条
  • [41] Use of recombinant activated factor vii (rFVIIa) in patients with uncontrolled bleeding: an evaluation of professional practices
    Langevin, Sophie
    Liou, Amelie
    Bignon, Estelle
    Vaissier, Elisabeth
    Ouattara, Alexandre
    Farinotti, Robert
    PHARMACY WORLD & SCIENCE, 2008, 30 (05): : 709 - 710
  • [42] Use of recombinant activated factor VII in cardiac surgery for an effective treatment of severe intractable bleeding
    Vanek, T
    Straka, Z
    Hrabak, J
    Jares, M
    Brucek, PJ
    Votava, J
    JAPANESE HEART JOURNAL, 2004, 45 (05): : 855 - 860
  • [43] Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding – a European perspective
    Jean-Louis Vincent
    Rolf Rossaint
    Bruno Riou
    Yves Ozier
    David Zideman
    Donat R Spahn
    Critical Care, 10
  • [44] Use of recombinant activated factor VII for uncontrolled bleeding in a haematology/oncology paediatric ICU cohort
    Shayeb, Akram Mesleh
    Li, Chen
    Kang, Guolian
    Reiss, Ulrike M.
    Elbahlawan, Lama
    BLOOD COAGULATION & FIBRINOLYSIS, 2020, 31 (07) : 440 - 444
  • [45] Recombinant activated factor VII use in the emergency department
    Fishman, P. E.
    Drumheller, B. C.
    Dubon, M. E.
    Slesinger, T. L.
    EMERGENCY MEDICINE JOURNAL, 2008, 25 (10) : 625 - 630
  • [46] Intraoperative use of recombinant activated coagulation factor VII
    Weiskopf, RB
    ANESTHESIOLOGY, 2002, 96 (06) : 1287 - 1289
  • [47] Intraoperative use of recombinant activated factor VII (rFVIIa)
    De Gasperi, A.
    MINERVA ANESTESIOLOGICA, 2006, 72 (06) : 489 - 494
  • [48] The role of recombinant-activated factor VII in bleeding trauma patients
    Dutton, Richard P.
    Conti, Bianca M.
    CURRENT OPINION IN ANESTHESIOLOGY, 2009, 22 (02) : 299 - 304
  • [49] Outcomes associated with the use of recombinant activated factor VII following pediatric cardiac surgery
    Firkbeiner, M.
    LeBlanc, J. G.
    Gunning, D. J.
    Scheepers, L. D.
    Campbell, A. I.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (01) : 244 - 245
  • [50] Treatment of bleeding after kidney biopsy with recombinant activated factor VII
    Maksimovic, Bojana
    Neretljak, Ivan
    Vidas, Zeljko
    Vojtusek, I. Kovacevic
    Tomulic, Katarina
    Knotek, Mladen
    BLOOD COAGULATION & FIBRINOLYSIS, 2012, 23 (03) : 241 - 243